2019-2023 Middle East Infectious Disease Testing Market: An 11-Country Analysis--Supplier Strategies, Test Volume and Sales Forecasts, Technology and Instrumentation Review

This new report provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The report provides granular market segmentation analysis and forecasts for over 100 microbiology tests; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the worlds major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes, Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Country Analyses

Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates

Market Segmentation Analysis

- Sales and market shares of major suppliers of
infectious disease diagnostic products in major countries by test.

- Test and sales forecasts for 100 infectious disease diagnostic
assays by country, individual test and market segment:

- Review of market dynamics, trends,
structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of major diseases,
including their etiology, current diagnostic tests,
vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
testing, including their operating
characteristics, features and selling prices.

Technology Review

- Assessment of emerging diagnostic technologies and their potential
applications for infectious disease testing.

- Companies developing or
marketing infectious disease diagnostic products
by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.

Opportunities and Strategies for Suppliers

- Emerging opportunities for new instrumentation,
reagent systems, IT and other products with significant market
appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains 985 pages and 145 tables


I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Overview of Major Tests,
Technologies and Instrumentation
A. Major Infectious Disease Tests
1. AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Carbapenemase
13. Chagas Disease
14. Chancroid
15. Chlamydia

16. Clostridium Difficile
17. Coronaviruses
18. Coxsackieviruses
19. Creutzfeldt-Jakobs Disease
20. Cryptosporidium Parvum
21. Cyclospora Cayetanensis
22. Cytomegalovirus
23. Ebola Virus
24. E. Coli
25. Echovirus
26. Encephalitis
27. Enteroviruses
28. Epstein-Barr Virus
30. Giardia Lamblia
31. Gonorrhea
32. Granuloma Inguinale
33. Hantavirus
34. Helicobacter Pylori
35. Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,
Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
HBe Ag, ALT/SGPT
36. Herpes Simplex Virus
37. Human Herpes Virus-6 (HHV-6)
38. Influenza Viruses
39. Legionella
40. Lyme Disease
41. Lymphogranuloma Venereum (LGV)
42. Malaria
43. Measles (Rubeola)
44. Meningitis
45. Microsporidium
46. Mononucleosis
47. Mumps
48. Mycoplasma
49. Norovirus
50. Papillomaviruses
51. Parvovirus B19
52. Pneumonia
53. Polyomaviruses
54. Pseudomonas Aeruginosa
55. Rabies
56. Respiratory Syncytial Virus (RSV)
57. Rhinoviruses
58. Rotavirus
59. Rubella
60. Salmonellosis
61. Septicemia
62. Shigellosis

63. Staphylococcus Aureus
64. Streptococci
65. Syphilis
66. Toxoplasmosis
67. Trichomonas Vaginalis
68. Tuberculosis
69. Vibrio
70. West Nile Virus
71. Yersina
B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
VII. Country Analyses: Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares
- Bahrain
- Iran
- Iraq
- Israel
- Jordan
- Kuwait
- Lebanon
- Oman
- Qatar
- Saudi Arabia
- United Arab Emirates


VIII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

List Of Tables

Bahrain
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Bahrain
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Iran
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Iran
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Iraq
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Iraq
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Israel
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Israel
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Jordan
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Jordan
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Kuwait
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Kuwait
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay

Lebanon
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Lebanon
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Oman
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Oman
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Qatar
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Qatar
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Saudi Arabia
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Saudi Arabia
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
United Arab Emirates
All Market Segments Infectious Disease
Test Volume Forecast by Assay
United Arab Emirates
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Major Companies Developing or
Marketing AIDS Tests
Major Companies Developing or
Marketing Adenovirus Tests
Major Companies Developing or
Marketing Bartonella Tests

Major Companies Developing or
Marketing Campylobacter Tests
Major Companies Developing or
Marketing Candida Tests
Major Companies Developing or
Marketing Carbapenemase Tests
Major Companies Developing or
Marketing Chlamydia Tests
Major Companies Developing or
Marketing Clostridium Tests
Major Companies Developing or
Marketing Coronavirus Tests
Major Companies Developing or
Marketing Cryptosporidium Tests
Major Companies Developing or
Marketing CMV Tests
Major Companies Developing or
Marketing Echovirus Tests
Major Companies Developing or
Marketing Enterovirus Tests
Major Companies Developing or
Marketing EBV Tests
Major Companies Developing or
Marketing Giardia Tests
Major Companies Developing or
Marketing Gonorrhea Tests
Major Companies Developing or
Marketing Hantavirus Tests
Major Companies Developing or
Marketing Helicobacter Pylori Tests
Major Companies Developing or
Marketing Hepatitis Tests

Major Companies Developing or
Marketing Herpes Tests
Major Companies Developing or
Marketing Influenza Tests
Major Companies Developing or
Marketing Legionella Tests
Major Companies Developing or
Marketing Lyme Disease Tests
Major Companies Developing or
Marketing Lymphogranuloma Tests
Major Companies Developing or
Marketing Malaria Tests
Major Companies Developing or
Marketing Measles Tests
Major Companies Developing or
Marketing Meningitis Tests
Major Companies Developing or
Marketing Microsporidium Tests
Major Companies Developing or
Marketing Mononucleosis Tests
Major Companies Developing or
Marketing Mumps Tests
Major Companies Developing or
Marketing Mycoplasma Tests
Major Companies Developing or
Marketing Norovirus Tests
Major Companies Developing or
Marketing Papilloma Virus Tests
Major Companies Developing or
Marketing Parvovirus Tests
Major Companies Developing or
Marketing Pneumonia Tests

Major Companies Developing or
Marketing RSV Tests
Major Companies Developing or
Marketing Rotavirus Tests
Major Companies Developing or
Marketing Rubella Tests
Major Companies Developing or
Marketing Salmonella Tests
Major Companies Developing or
Marketing Septicemia Tests
Major Companies Developing or
Marketing Shigella Tests
Major Companies Developing or
Marketing Staphylococci Tests
Major Companies Developing or
Marketing Streptococci Tests
Major Companies Developing or
Marketing Syphilis Tests
Major Companies Developing or
Marketing Toxoplasmosis Tests
Major Companies Developing or
Marketing Trichomonas Tests
Major Companies Developing or
Marketing Tuberculosis Tests
Major Companies Developing or
Marketing West Nile Tests
Major Companies Developing or
Marketing Yersinia Tests

2019-2023 US POC Lipid Testing Market: Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers

This new 305-page report from contains 22 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and

USD 2900 View Report

2019-2023 POC Lipid Testing Market: Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers

This new 340-page report from contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and

USD 4350 View Report

The Connected Consumer Survey 2018: OTT services in the Middle East and North Africa

This report focuses on aspects of  Connected Consumer Survey that relate to the behaviour, preferences and plans of smartphone users in the Middle East and North Africa (MENA). In particular,

USD 4999 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available